Sanf Co. Ltd., a leading fertilizer, health care, collagen, food raw material import .export trading company in Japan has announced expansion plans for China , South East Asia and the Middle East amid COVID-19 pandemic.  

Established in Tokyo in 2000, Sanf achieved viable growth and became a leading name within two decades operating quality manufacturing of natdokinase and glycosamine.  

Natdokinase is a fermentation based health care food which has its origin in  Natto — a Japanese food made from soyabeans fermented with Bacillus subtilis var. 

With continued growth and expansion of business, the company's large exports include amino fertilizer to Taiwan, hwasung fertilizer to Germany, collagen to France and Chlorella to South Korea.  

With its new expansion, Sanf plans to supply glucosamine health care foods (natural amino sugar) in the form of pills.  

Throughout COVID-19 pandemic, Sanf was working on numerous innovation and pilot programs to achieve robust manufacturing of health care brands that may help stakeholders currently engaged in developing immune supplements.

Image source (http://www.3fj.jp/) 

It should be noted that Japanese health food products such as natdokinase, glycosamine are manufactured in Japan using the raw materials exported from China and therefore, partnership with Sanf may open plethora of bilateral trade supply opportunities to entrepreneurs from China and South East Asia.  

Trained from Tokyo university, CEO of Sanf Choi Chang-beom  said, Sanf is committed to build a prosperous future of mankind and health industry and therefore we continue to push forward with new vistas by signing agreements in China and South East Asia amid this COVID-19.  

With the vision of sustainable and shared growth, Sanf is looking for reliable partners in China , South East Asia and the Middle-East to share its best products to global buyers and become Sanf’s long-term distributors.  

For distributorship and media inquiries, please refer to http://www.3fj.jp/contact/contact.html